Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
about
Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigenArchaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomesLiposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responsesInduction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.A mucosal vaccination approach for herpes simplex virus type 2.Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.Nanoparticle delivery systems in cancer vaccines.Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination constructEncapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes.A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protectionRole of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines.Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy.Archaeosomes: an excellent carrier for drug and cell delivery.Fusogenic potential of sperm membrane lipids: nature's wisdom to accomplish targeted gene delivery.Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.Malaria vaccine: roadblocks and possible solutions.Micelle-bound conformation of a hairpin-forming peptide: combined NMR and molecular dynamics study.Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development
P2860
Q30361416-B32C9356-89A7-4BC2-B60D-EBE3FE1AD9B0Q30397437-02A3AA16-FB49-49E3-AF81-AC315A0423E1Q33202223-1A555587-788F-44AC-994B-7A02D194A227Q33755289-710F062A-7748-4B19-AE84-7802604471DBQ33867079-BFF16D0A-06E4-4B6A-BC26-41646D992BB0Q33959996-FD56BDAC-8087-498C-993B-74E1C07D1A1DQ33994987-A32D8519-F047-4612-961C-2C5350E6B9B3Q34002944-E191D2A0-5AF7-4BD0-AFDA-E7FDF25A6E2AQ34217826-3F188725-A080-42A2-9EC3-C05F554A5014Q34345308-49810E47-3727-43D4-9B65-0E28AB5F2F21Q34558350-2E11346F-E44C-4AB0-AF3C-382DA4D0D5CEQ35666215-B81116C7-85B3-41BB-9D08-1DF717DDACA5Q36574571-276F1456-7E74-4C30-905B-D66063EE9C8FQ36616720-1C714633-457F-44CD-B082-2A2CA01CE227Q36673743-C1BF7F5C-9592-4C94-9A39-72E09B5CCA3AQ36787928-62056015-D1D7-4FA0-9901-2A32DCB815D2Q37316019-BFB411F5-914B-4017-9720-82E7E910613EQ38032881-9B884CFB-00CF-4580-9CFC-64AB7F86B8A9Q38177364-86C00F31-0621-4BAB-A8BD-B806F8278E6CQ38380341-C6521B45-00A3-4C9A-8F79-3AF290D89EABQ40297361-4B2B86DA-943A-49B7-B0D0-208F888E9E00Q40735997-1423A72B-A119-438D-A64B-ACCE8551F734Q40847091-89A4E320-335E-44D4-9F60-866E6D6CF468Q44181627-F0FC418D-E7B1-403C-880B-BE28A8698936Q47105347-76C197A8-1C6D-4AC4-9826-48BDBE875926Q56864807-D7589918-DAE7-4268-AB42-C30A012C19B4
P2860
Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Liposomes as carriers of pepti ...... ted and unconjugated peptides.
@en
type
label
Liposomes as carriers of pepti ...... ted and unconjugated peptides.
@en
prefLabel
Liposomes as carriers of pepti ...... ted and unconjugated peptides.
@en
P2093
P2860
P921
P1476
Liposomes as carriers of pepti ...... ted and unconjugated peptides.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1995.TB00075.X
P577
1995-06-01T00:00:00Z